195 related articles for article (PubMed ID: 8373773)
1. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
Liu JN; Harpel PC; Pannell R; Gurewich V
Biochemistry; 1993 Sep; 32(37):9694-700. PubMed ID: 8373773
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) regulates plasmin generation and inhibition.
Edelberg J; Pizzo SV
Chem Phys Lipids; 1994 Jan; 67-68():363-8. PubMed ID: 8187236
[TBL] [Abstract][Full Text] [Related]
4. Fibrin-bound lipoprotein(a) promotes plasminogen binding but inhibits fibrin degradation by plasmin.
Liu J; Harpel PC; Gurewich V
Biochemistry; 1994 Mar; 33(9):2554-60. PubMed ID: 8117716
[TBL] [Abstract][Full Text] [Related]
5. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
[TBL] [Abstract][Full Text] [Related]
6. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
Liu JN; Gurewich V
Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein.
Simon DI; Fless GM; Scanu AM; Loscalzo J
Biochemistry; 1991 Jul; 30(27):6671-7. PubMed ID: 1829635
[TBL] [Abstract][Full Text] [Related]
8. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
Liu JN; Gurewich V
Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo J; Weinfeld M; Fless GM; Scanu AM
Arteriosclerosis; 1990; 10(2):240-5. PubMed ID: 2138452
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
[TBL] [Abstract][Full Text] [Related]
11. Substrate inhibition of fibrin-dependent plasminogen activation by tissue-type plasminogen activator.
Liu J; Gurewich V
J Biol Chem; 1993 Jun; 268(17):12257-9. PubMed ID: 8509362
[TBL] [Abstract][Full Text] [Related]
12. Activation of plasminogen by pro-urokinase. I. Mechanism.
Lijnen HR; Zamarron C; Blaber M; Winkler ME; Collen D
J Biol Chem; 1986 Jan; 261(3):1253-8. PubMed ID: 2935528
[TBL] [Abstract][Full Text] [Related]
13. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.
Pannell R; Gurewich V
Blood; 1986 May; 67(5):1215-23. PubMed ID: 3083889
[TBL] [Abstract][Full Text] [Related]
14. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
15. Does Lp(a) lipoprotein inhibit the fibrinolytic system?
Halvorsen S; Skjønsberg OH; Berg K; Ruyter R; Godal HC
Thromb Res; 1992 Nov; 68(3):223-32. PubMed ID: 1471070
[TBL] [Abstract][Full Text] [Related]
16. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
Sun Z; Liu JN
Proteins; 2005 Dec; 61(4):870-7. PubMed ID: 16231330
[TBL] [Abstract][Full Text] [Related]
18. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
Liu JN; Pannell R; Gurewich V
J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
[TBL] [Abstract][Full Text] [Related]
19. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation.
Ezratty A; Simon DI; Loscalzo J
Biochemistry; 1993 May; 32(17):4628-33. PubMed ID: 8485140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
